US Stock
Closed Market
AbCellera Stock
•ABCLClosed Market
$4,93
+$0,09(1,97%)Past Day
+$0,09(1,97%)After Hours
About AbCellera
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 596 full-time employees. The company went IPO on 2020-12-11. Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ
Employees596
HeadquarterVancouver, United States
Websiteabcellera.com
SymbolABCL
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
SAVA
HAL
ASTS
TSM
TDOC
LUV
BKR
NNDM
VFC
BBWI
CAH
EC
MCK
ARKO
QVCGASAVAHALASTSTSMTDOCLUVBKRNNDMVFCBBWICAHECMCKARKOQVCGA
SAVA$3,54
+52,47%
HAL$24,24
+7,19%
ASTS$54,63
+11,83%
TSM$282,29
+3,54%
TDOC$8,5
+3,79%
LUV$33,34
+3,22%
BKR$49,18
+3,16%
NNDM$1,58
+7,18%
VFC$14,9
+3,94%
BBWI$26,66
+2,93%
CAH$153,47
+4,07%
EC$9,41
+4,38%
MCK$745,06
+6,90%
ARKO$4,88
+3,50%
QVCGA$13,32
+4,02%
SAVA$3,54
+52,47%
HAL$24,24
+7,19%
ASTS$54,63
+11,83%
TSM$282,29
+3,54%
TDOC$8,5
+3,79%
LUV$33,34
+3,22%
BKR$49,18
+3,16%
NNDM$1,58
+7,18%
VFC$14,9
+3,94%
BBWI$26,66
+2,93%
CAH$153,47
+4,07%
EC$9,41
+4,38%
MCK$745,06
+6,90%
ARKO$4,88
+3,50%
QVCGA$13,32
+4,02%
